Canada approved a generic version of semaglutide (the active ingredient in Ozempic) made by Dr. Reddy's Laboratories. This generic copy is cheaper and could give more people access to the weight-loss and diabetes drug.

• •Canada approved Dr. Reddy's generic version of semaglutide
• •Semaglutide is the active ingredient in Novo Nordisk's Ozempic
• •Generic is cheaper and aims to broaden access for diabetes and weight loss

Dr. Reddy's Laboratories received approval from Health Canada to sell a generic version of semaglutide injection in Canada. This is the first generic copy of the popular weight-loss and diabetes drug to be approved there.

• •Dr. Reddy's received Health Canada approval for generic semaglutide injection
• •First generic semaglutide approved in Canada
• •Approval covers weight-loss and diabetes indications

Dr. Reddy's Laboratories received approval from Health Canada (the Canadian health regulator) to sell a generic version of semaglutide injection in 2 mg and 4 mg pen formats. This approval means Canadians will have access to a cheaper copy of this popular weight-loss and diabetes drug.

• •Health Canada approved Dr. Reddy's generic semaglutide injection
• •Approval covers 2 mg and 4 mg pen formats